StockClub

ANIK

ANIKAnika Therapeutics, Inc.$ --
Anika Therapeutics, Inc.

Anika Therapeutics, Inc.

ANIK

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
30M USD
YoY +13.2%
Operating Income
-5M USD
YoY -28.1%
Net Income
-5M USD
YoY -3.8%
EPS
-0.37$
YoY -8.8%

Revenue

$29.6M
FY2024 Q2$71.2M
$71.2M
Q2
FY2024 Q3$110M
$110M
Q3
FY2024 Q4$108.7M
$108.7M
Q4
FY2025 Q1$26.2M
$26.2M
Q1
FY2025 Q2$54.4M
$54.4M
Q2
FY2025 Q3$82.2M
$82.2M
Q3
FY2025 Q4$112.8M
$112.8M
Q4
FY2026 Q1$29.6M
$29.6M
Q1
Actual
+$3.4M (+13.2%)

Net Income

$-5.1M
FY2024 Q2$-4.6M
$-4.6M
Q2
FY2024 Q3$-34.5M
$-34.5M
Q3
FY2024 Q4$-56.4M
$-56.4M
Q4
FY2025 Q1$-4.9M
$-4.9M
Q1
FY2025 Q2$-8.8M
$-8.8M
Q2
FY2025 Q3$-11.2M
$-11.2M
Q3
FY2025 Q4$-10.9M
$-10.9M
Q4
FY2026 Q1$-5.1M
$-5.1M
Q1
Actual
$-183,000 (-3.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$130.5M
Est:$131.3M
FY2020MISS
$130.5M
FY2021BEAT
Actual:$147.8M
Est:$144M
FY2021BEAT
$147.8M
FY2022MISS
Actual:$113.8M
Est:$154.3M
FY2022MISS
$113.8M
FY2023MISS
Actual:$120.8M
Est:$166.9M
FY2023MISS
$120.8M
FY2024MISS
Actual:$119.9M
Est:$150.2M
FY2024MISS
$119.9M
FY2025BEAT
Actual:$112.8M
Est:$111M
FY2025BEAT
$112.8M

Analyst Estimates